II. Mechanism: Muscarinic Antagonists
- M1, M4, M5 Receptor Antagonist (CNS Effects)
- M2 Receptor Antagonist (Cardiac Effects)
- Increased AV Nodal Conduction (Tachycardia, Arrhythmias)
- M3 Receptor Antagonist (Smooth Muscle and Exocrine Glands)
III. Mechanism: Nicotinic Antagonists
-
Ganglionic Blocking Agents (act at Autonomic Nervous System)
- Sympathetic effects
- Vasodilation
- Parasympathetic effects
- Mydriasis
- Decreased gastrointestinal motility and Constipation
- Tachycardia
- Urinary Retention
- Sympathetic effects
- Neuromuscular Blocking Agents (act at Neuromuscular Junction)
- Background
- Acetylcholine acts at the Neuromuscular Junction (NMJ) with 2 of 5 receptor sites specific for Acetylcholine binding
- When both Acetylcholine receptors are bound, ion channels open allowing Sodium influx and Membrane Depolarization
- Resulting impulse triggers muscular contraction
- Nondepolarizing Neuromuscular Blocking Agent (Vecuronium, Rocuronium)
- Acetylcholine Competitive Receptor Antagonists
- Inhibited Muscle Contraction (Muscle relaxation, paralysis)
- Depolarizing Neuromuscular Blocking Agent (Succinylcholine)
- Competitive Cholingergic Agonist
- Succinylcholine is an Agonist that binds and blocks Acetylcholine from binding until it dissociates from receptor site
- Transient muscle Fasciculations and contractions (due to Agonist activity), followed by paralysis
- Background
IV. Medications: Muscarinic Antagonists
- Background
- Agents listed here are specifically indicated for their Anticholinergic activity
- Contrast with other agents with Anticholinergic activity as an adverse effect (e.g. Antihistamines, Tricyclic Antidepressants)
- Belladona Alkaloids
- Atropine
- Prototypal CholinergicAntagonist against which other agents are compared
- Extracted from plants such as deadly nightshade (atropa belladona)
- Used in Unstable Bradycardia and Bladder spasms (e.g. B&O suppositories)
- Scopolamine
- Used in Motion Sickness and perioperative Nausea and Vomiting
- Hyoscyamine (Levsin)
- Used as a gastrointestinal antispasmodic agents
- Atropine
- Synthetic tertiary agents
- Gastrointestinal Antispasmodic Agents
- Dicyclomine (Bentyl)
- Mebeverine
- Oxyphencyclimine
- Trimebutine
- Bladder Antispasmodic
- Treatment of Parkinsonism, Extrapyramidal Side Effects and other Movement Disorders
- Trihexylphenidyl (Artane)
- Biperiden (Akineton)
- Procyclidine (Kemadrin)
- Benztropine (Cogentin)
- Ocular (Cycloplegic, Mydriatic)
- Homatropine
- Gastrointestinal Antispasmodic Agents
- Synthetic quaternary agents
- Gastrointestinal Antispasmodic Agents
- Methscopolamine Bromide (Pamine)
- Clidinium (Bromide)
- Glycopyrolate (Robinul)
- Isopropamide
- Methantheline
- Tridihexethyl
- Gastrointestinal Antispasmodic Agents
V. Medications: Neuromuscular Blockers
VI. Complications
- See Anticholinergic Toxicity
-
Altered Level of Consciousness (esp. elderly)
- Delirium or confusion (may mimic Dementia)
- Memory Impairment
- Delirium
- Obtundation
VII. Resources
VIII. References
- Olson (2020) Clinical Pharmacology, Medmaster, Miami, p. 28-9